Search Results 851-860 of 17830 for secondary infertility
... second (FEV) and quality-of-life measures in patients with uncontrolled, moderate-to-severe asthma, with greater efficacy observed in those with a high ...
Subject has concomitant active second malignancies unless remission was achieved at least 3 years prior to study entry and subject is no longer on therapy for ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
This study is intended to develop and validate a novel wearable dynamic loading assessment tool and to demonstrate the association between the measures from ...
Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single ...
The purpose of this study is to determine whether oral inosine dosed to moderately elevate serum urate (from ≤5.7 mg/dL to 7.1-8.0 mg/dL) over 2 years slows ...
... Secondary hyperparathyroidism, Parathyroid adenoma. Show more areas of focus for Patricia A. Cronin, M.D.. Research. Doctors discussing imaging test results.
Anderson G, Halli Demeter S, Drechsel K, Underhill M, Pradhan S, Radway N. Hypercholesterolemia management in a patient with mitochondrial encephalomyopathy ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!